Alpha Teknova (TKNO) Income from Continuing Operations (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Income from Continuing Operations came in at 4555000.0 in Q1 2026, up 1.94% year-on-year from 4468421.33 in Q1 2025, and up 3.64% on a QoQ basis from 4727000.0 in Q4 2025.
Alpha Teknova (TKNO) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Income from Continuing Operations data on file, last reported at 4555000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 1.94% year-over-year to 4555000.0 in Q1 2026; TTM through Mar 2026 was 17159000.0, a 26.33% increase from a year earlier, with the FY2025 full-year figure at 17208000.0, up 35.66% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 4555000.0, up from 4727000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for TKNO reached as high as 3570000.0 in Q2 2025 and fell as low as 22448000.0 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 7937117.65 across 5 years, with a median of 6198000.0 in 2022.
- Across the five-year window, Income from Continuing Operations sank 732.98% in 2022 and jumped 54.77% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 15196000.0 in 2022, then climbed by 27.88% to 10960000.0 in 2023, then soared by 47.82% to 5719000.0 in 2024, then advanced by 17.35% to 4727000.0 in 2025, then gained by 3.64% to 4555000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 4555000.0 in Q1 2026, 4727000.0 in Q4 2025, and 4307000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | -4.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.56 Mn |
| Dec 31, 2025 | -4.73 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -3.57 Mn |
| Mar 31, 2025 | -4.65 Mn |
| Dec 31, 2024 | -5.72 Mn |
| Sep 30, 2024 | -7.57 Mn |
| Jun 30, 2024 | -5.36 Mn |
| Mar 31, 2024 | -8.10 Mn |
| Dec 31, 2023 | -10.96 Mn |
| Sep 30, 2023 | -10.15 Mn |
| Jun 30, 2023 | -7.15 Mn |
| Mar 31, 2023 | -8.82 Mn |
| Dec 31, 2022 | -15.20 Mn |
| Sep 30, 2022 | -22.45 Mn |
| Jun 30, 2022 | -6.20 Mn |
| Mar 31, 2022 | -5.46 Mn |
| Dec 31, 2021 | -6.48 Mn |
| Sep 30, 2021 | -3.24 Mn |
| Jun 30, 2021 | -2.23 Mn |